Nucliq Biologics
1 known investors
Find your way into Nucliq Biologics
Sign up to see every warm intro you have to Nucliq Biologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nucliq Biologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nucliq Biologics analyzes the gut microbiome using AI, machine learning, and multi-omics science (metagenomics, transcriptomics, metabolomics) to identify microbial signatures and develop precision therapeutics. The company targets chronic, multifactorial diseases through therapies that modulate neuroimmune, gut-brain, and gut-skin axes.
Investors · 1
In the news
Frequently asked questions
- What does Nucliq Biologics do?
- Nucliq Biologics analyzes the gut microbiome using AI, machine learning, and multi-omics science (metagenomics, transcriptomics, metabolomics) to identify microbial signatures and develop precision therapeutics. The company targets chronic, multifactorial diseases through therapies that modulate neuroimmune, gut-brain, and gut-skin axes.
- Who are Nucliq Biologics's investors?
- Nucliq Biologics's investors include Women's Equity Lab.
